$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[미국특허] Combination therapy for treating disease 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-039/395
출원번호 US-0831886 (2004-04-26)
등록번호 US8038994 (2011-10-04)
발명자 / 주소
  • Schultes, Birgit C.
  • Nicodemus, Christopher F.
  • Noujaim, Antoine A.
  • Madiyalakan, Ragupathy
출원인 / 주소
  • Quest Pharmatech Inc.
대리인 / 주소
    Sheridan Ross P.C.
인용정보 피인용 횟수 : 1  인용 특허 : 54

초록

Disclosed are methods for treating cancer comprising administering a xenotypic antibody and a chemotherapeutic drug to a patient suffering from cancer. Also disclosed is a method for inducing a host immune response in a patient against a multi-epitopic in vivo tumor antigen present in the host serum

대표청구항

We claim: 1. A method for treating cancer, comprising administering to a patient suffering from cancer a chemotherapeutic drug, and a composition comprising an unlabeled xenotypic monoclonal antibody specific for a multi-epitopic in vivo antigen present in the patient's serum, wherein the multi-epit

이 특허에 인용된 특허 (54) 인용/피인용 타임라인 분석

  1. Raso Victor ; Paulus Henry, Anti-idiotype vaccines to elicit catalytic antibodies.
  2. Shawver Laura K. ; Brandis John W. ; Mann Elaina ; Hancock Miriam E. C. ; Mischak Ronald P. ; Monahan John J., Anti-neoplastic drugs in cancer therapy.
  3. Buurman Wim (Maastricht NLX), Antibodies for use in antilymphocyte antibody therapy.
  4. Kufe Donald (Wellesley MA), Antibodies specific for the DF3 carcinoma associated antigen.
  5. Taylor-Papadimitriou Joyce (Berkhamsted GB2) Gendler Sandra (London GB2) Burchell Joy (Uckfield GB2), Antibody against human mucin core protein and method of preparing and using same.
  6. Senter Peter D. (Seattle WA) Saulnier Mark G. (Middletown CT) Brown Joseph P. (Seattle WA) Kerr David E. (Seattle WA), Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells.
  7. Arakawa Tsutomu ; Kita Yoshiko, Antibody-induced apoptosis.
  8. Sweet Frederick (St. Louis County MO) Rosik Leonard O. (St. Louis County MO), Anticancer drug - antibody conjugates and method for preparing same.
  9. Zanetti Maurizio (La Jolla CA), Antigenized antibodies and genes.
  10. Koprowski Hilary (Wynnewood PA) Steplewski Zenon (Strafford PA) Herlyn Meenhard (Wynnewood PA), Detection of colorectal carcinoma.
  11. Chu Tsann Ming (Williamsville NY) Papsidero Lawrence D. (Orchard Park NY) Croghan Gary A. (Rochester NY), Diagnostic immunoassay methods using monoclonal antibody F36/22 which is specific for human breast carcinoma cells.
  12. Morgan ; Jr. Alton C. (Edmonds WA) Woodhouse Clive S. (Seattle WA) McIntyre Robert F. (Seattle WA), Enhanced production of antibodies utilizing insolubilized immune complexes.
  13. Barber Brian H. (Mississauga CAX) Carayannotis George (Scarborough CAX), Enhancement of antigen immunogenicity.
  14. Barber Brian H. (Mississauga CAX) Carayannotis George (Toronto CAX), Enhancement of antigen immunogenicity.
  15. Hyuga Hiroaki,JPX ; Okazaki Yoji,JPX, Etalon and single longitudinal mode laser.
  16. DeVico Anthony L. (Alexandria VA) Pal Ranajit (Gaithersburg MD) Sarngadharan Mangalasseril G. (McLean VA), HIV immunogenic complexes.
  17. Liang,Yanbin; Woodward,David F., Human COX-1 alternatively spliced variants and methods of using same.
  18. Queen Cary L. (Los Altos CA) Selick Harold E. (Belmont CA), Humanized immunoglobulins.
  19. Sims John E. ; Virca G. Duke ; Bird Timothy A. ; Anderson Dirk M., IL-1/TNF-.alpha.-activated kinase (ITAK), and methods of making and using the same.
  20. Cheever Martin A. ; Disis Mary L., Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is a.
  21. Kokolus William J. ; Fritsche Herbert A. ; Johnston Dennis A., Immunogenic peptides of prostate specific antigen.
  22. Koprowski Hilary (Wynnewood PA) Herlyn Dorothee (Wynnewood PA) DeFreitas Elaine C. (Villanova PA), Induction of antibody response to solid tumors with anti-idiotype antibodies.
  23. John Wityak ; Aleksandra Ewa Tobin, Integrin receptor antagonists.
  24. Goldenberg Milton David, Intraoperative, intravascular, and endoscopic tumor and lesion detection, biopsy and therapy.
  25. Diamandis Eleftherios P.,CAX ; Redshaw Russell,CAX, Localization and therapy of non-prostatic endocrine cancer with agents directed against prostate specific antigen.
  26. Rhodes Buck A. (1104 Stanford Dr. ; NE. Albuquerque NM 87106), Method for compounding and testing patient specific monoclonal antibodies and monoclonal antibody fragments for in vivo.
  27. Nudelman Edward (Seattle WA) Singhal Anil (Seattle WA) Clausen Henrik (Seattle WA) Hakomori Sen-itiroh (Seattle WA), Method for the production of monoclonal antibodies directed to tumor-associated gangliosides and fucogangliosides.
  28. Unger Evan C., Method of magnetic resonance focused surgical and therapeutic ultrasound.
  29. Cheever Martin A. ; Disis Mary L., Methods for eliciting or enhancing reactivity to HER-2/neu protein.
  30. Storkus Walter J. ; Lotze Michael T., Methods for isolation and use of T cell epitopes eluted from viable cells in vaccines for treating cancer patients.
  31. Hakomori Sen-itiroh (Mercr Island WA), Methods for the production of antibodies and induction of immune responses to tumor-associated ganagliosides by immuniza.
  32. Hakomori Sen-itiroh (Mercr Island WA), Methods for the production of antibodies and induction of immune responses to tumor-associated gangliosides by immunizat.
  33. Hakomori Sen-itiroh (Mercr Island WA), Methods for the production of antibodies and induction of immune responses to tumor-associated gangliosides by immunizat.
  34. Byers Vera S. (San Francisco CA) Baldwin Robert W. (Long Eaton GB2), Methods for the selective suppression of an immune response to dust mite der Pi.
  35. Courtenay-Luck Nigel S. (London GBX), Minimum recognition unit of a PEM mucin tandem repeat specific monoclonal antibody and detection method using same.
  36. Tsang Kwong Y. (Bethesda MD) Arlen Myron (Great Neck NY), Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor.
  37. Hudziak Robert M. ; Ullrich Axel ; Fendly Brian M., Monoclonal antibodies directed to the HER2 receptor.
  38. O'Brien Timothy J., Monoclonal antibodies which identify the glycoprotein carrying the CA 125 epitope.
  39. Chatterjee Malaya ; Foon Kenneth A. ; Chatterjee Sunil K., Monoclonal antibody 1A7 and related polypeptides.
  40. Gold,David V.; Goldenberg,David M.; Hansen,Hans J., Monoclonal antibody cPAM4.
  41. Webb Thomas E. (Columbus OH) Stromberg Paul C. (Westerville OH) Schumm Dorothy E. (Patroit OH), Monoclonal antibody to canine placental oncofetal protein for detecting cancer.
  42. Goletz Theresa J. ; Berzofsky Jay A. ; Helman Lee J., Peptides containing a fusion joint of a chimeric protein encoded by DNA spanning a tumor-associated chromosomal translocation and their use as immunogens.
  43. Eder Gerald,ATX ; Eibl Johann,ATX, Pharmaceutical composition containing a neutralized virus and use thereof.
  44. Leveugle, Beatrice; Madiyalakan, Ragupathy; Noujaim, Antoine A.; Schultes, Birgit, Reagents and methods for inducing an immune response to prostate specific antigen.
  45. Jette Diane (Edmonton CAX) Van Heel Anneke (Ardrossan CAX) Suresh Mavanur (Edmonton CAX), Screening for antibodies which bind carbohydrate epitopes of tumor-associated antigens, and uses thereof.
  46. Hellstrom Karl E. (Seattle WA) Hellstrom Ingegerd (Seattle WA) Goodman Gary E. (Bellevue WA), Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy.
  47. Romet-Lemonne Jean Loup,FRX ; Fanger Michael W. ; Guyre Paul M. ; Gosselin Edmund J., Targeted immunostimulation with bispecific reagents.
  48. Sykes Thomas R.,CAX ; Madiyalakan Ragupathy,CAX ; Baum Richard P.,DEX ; Noujaim Antoine A.,CAX, Therapeutic composition and method of treatment.
  49. Dunn Joseph T. (Holliston MA), Therapeutic enzyme-antibody complexes.
  50. St. Remy Jean-Marie (Grez-Doiceau BEX) Lebrun Philippe (Namur BEX) Lebecque Serge (Brussels BEX) Masson Pierre (Brussels BEX), Treatment of allergy.
  51. Hanna ; Jr. Michael (Frederick MD) Haspel Martin V. (Silver Spring MD) Hoover ; Jr. Herbert C. (Port Jefferson NY), Tumor associated monocoloal antibodies derived from human B-cell line.
  52. Goldenberg Milton D. (11837 Gainsborough Rd. Potomac MD 20854), Tumor localization and therapy with labeled anti-CEA antibody.
  53. Goldenberg Milton D. (11837 Gainsborough Rd. Potomac MD 20854), Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers.
  54. Elliott Robert L. (17310 Masters Pointe Ct. Baton Rouge LA 70810) Head Jonathan F. (6144 Hagerstown Dr. Baton Rouge LA 70817), Vaccination of cancer patients using tumor-associated antigens mixed with interleukin-2 and granulocyte-macrophage colon.

이 특허를 인용한 특허 (1) 인용/피인용 타임라인 분석

  1. Schultes, Birgit C.; Nicodemus, Christopher F., Methods for improving the bioactivity of therapeutic IgE antibodies for the treatment of disease.

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 특허

해당 특허가 속한 카테고리에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로